n-prolyl palmitoyl tripeptide-56 acetate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
Pregnancy-safe products containing n-prolyl palmitoyl tripeptide-56 acetate










Related ingredients
Frequently asked questions
- n-prolyl palmitoyl tripeptide-56 acetate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
- n-prolyl palmitoyl tripeptide-56 acetate est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no reproductive or lactation-specific hazard identified in authoritative sources. No evidence of transfer in milk; dermal exposure from cosmetics is expected to be low but measurable (e=1). Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- n-prolyl palmitoyl tripeptide-56 acetate est-il sûr pour la peau de bébé ?
- No infant‑specific hazard data located. Because the ingredient likely has low but measurable dermal absorption in adults (e=1) and infant skin has higher permeability and higher surface‑area‑to‑weight, exposure score is increased by +1 to e=2 for 0–3 year olds. No studies demonstrating infant toxicity were found. Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- Comment VeriMom évalue-t-il n-prolyl palmitoyl tripeptide-56 acetate ?
- VeriMom évalue n-prolyl palmitoyl tripeptide-56 acetate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à n-prolyl palmitoyl tripeptide-56 acetate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à n-prolyl palmitoyl tripeptide-56 acetate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.